Myoung-Ok Kwon

Myoung-Ok Kwon, Prof. PhD, currently serves as Co-Chair and Member of the Evaluation Board at Wyss Zurich, focusing on regenerative medicine, robotics, and medical devices. As an Adjunct Professor at the Korea Advanced Institute of Science and Technology, expertise encompasses venture capital, biotech, digital health, and healthcare digital transformation. Myoung-Ok holds the position of Investment Partner in Digital Health at Swisscom Ventures and serves on the Board of Directors at Medimaps Group and Neo Medical, while acting as a Board Observer for Nanolive SA. Previous roles include Independent Board Director at NLS Pharmaceutics AG and Head of Healthcare Investment at PMG Fonds Management AG. The foundation of Myoung-Ok's career in biotech investment was established as Founder of the Biotech Core Value Fund and Venture Partner at Arcus Ventures. Academic credentials include a PhD in Biochemical Sciences from the University of Basel and multiple executive education programs at Harvard Business School.